Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Encoding the glucose identity by discrete hypothalamic neurons via the gut-brain axis.

Neuron·2025

Same author

Low-Intensity Physical Exercise is Associated with Improved Myelination and Reduced Microglial Activation in a Cuprizone-Induced Demyelination Model.

Neurochemical research·2025

Same author

Therapeutic potential of cell-permeable PEP-1-Srxn1 in mitigating oxidative and ischemic damage in the hippocampus.

Neurochemistry international·2025

Same author

Neuroprotective Effects of Chaperonin Containing TCP1 Subunit 2 (CCT2) on Motor Neurons Following Oxidative or Ischemic Stress.

Neurochemical research·2024

Same author

TAT-PPA1 protects against oxidative stress-induced loss of dopaminergic neurons.

Molecular and cellular neurosciences·2024

Same author

PFKFB3 ameliorates ischemia-induced neuronal damage by reducing reactive oxygen species and inhibiting nuclear translocation of Cdk5.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat

In Koo Hwang¹, Il Yong Kim, Eun Jung Joo

¹Department of Anatomy and Cell Biology, College of Veterinary Medicine, Seoul National University, Seoul, South Korea.

Neurochemical Research

|January 14, 2010

Summary

Metformin, a type 2 diabetes drug, was studied for its effects on brain cell growth. Metformin treatment normalized reduced neuroblast differentiation and cell proliferation in diabetic rats.

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jun 17, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Area of Science:

Neuroscience
Endocrinology
Pharmacology

Background:

Type 2 diabetes is linked to reduced neurogenesis.
Zucker diabetic fatty (ZDF) rats serve as a model for type 2 diabetes.
Metformin is a common treatment for type 2 diabetes.

Purpose of the Study:

To investigate the impact of metformin on cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus of ZDF rats.
To assess if metformin can counteract diabetes-induced deficits in neurogenesis.

Main Methods:

Oral administration of metformin to 14-week-old ZDF rats for 2 weeks.
Assessment of blood glucose levels.
Immunohistochemical analysis of Ki67 (proliferation marker) and doublecortin (DCX, neuroblast marker) in the subgranular zone of the hippocampal dentate gyrus (SZDG).

Main Results:

Vehicle-treated ZDF rats exhibited higher blood glucose levels compared to Zucker lean control (ZLC) rats.
Metformin treatment significantly reduced blood glucose levels in ZDF rats.
ZDF rats showed significantly lower numbers of Ki67- and DCX-immunoreactive cells in the SZDG compared to ZLC rats.
Metformin treatment significantly increased Ki67- and DCX-immunoreactive cells in the SZDG of ZDF rats compared to vehicle-treated ZDF rats.

Conclusions:

Type 2 diabetes significantly impairs cell proliferation and neuroblast differentiation in the SZDG.
Metformin treatment effectively normalizes these deficits in diabetic rats.
Metformin may hold therapeutic potential for mitigating diabetes-related cognitive decline by promoting neurogenesis.